The OCULAB Program, hosted by ARPA-H, aims to develop an innovative wearable biomarker measurement system using tear-based sensors for real-time continuous health monitoring. The primary focus is on addressing Dry Eye Disease (DED) with a precise drug dosing system, using a closed-loop delivery platform that can be inserted into the tear duct.

The OCUBLAB system will use nanosensors and advanced technologies like wearable tech, bioassays, nanotechnology, and AI algorithms to revolutionize continuous biomarker monitoring for DED and other conditions as well. Diverse technical teams (U.S based) are encouraged to collaborate on research proposals aimed at advancing this vision.

Solution Summaries are due by January 27, 2025, 5:00 PM EST. Multiple awards are available. For more details on team and proposal requirements, visit the program page here!